Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study — Mette Søgaard (2024) | RDL Network
Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study
Article 2024 en
Authors
MS
Mette Søgaard
MJ
Martin Jensen
AH
Anette Arbjerg Højen
Abstract
1 min read
Frail patients with atrial fibrillation are often untreated with OAC in routine clinical care despite an indication for stroke prevention. The NCB balancing thromboembolic events and major bleeding was in favor of anticoagulation but decreased with advancing age and increasing frailty.
Pietro Caliandro, Virginia Cancelloni, M. De Marco, Giuseppe Reale, Aurelia Zauli, Giancarlo Agnelli, Valeria Caso, Cecilia Becattini, Paolo Calabresi, Maria Giulia Mosconi, Michela Giustozzi, Georgios Tsivgoulis, David Seiffge, Stefan T. Engelter, Philippe Lyrer, Alexandros A. Polymeris, Tolga Dittrich, Annaelle Zietz, Gian Marco De Marchis, Jukka Putaala, Daniel Strbian, Liisa Tomppo,
Discussion(0)
No comments yet. Be the first to comment.